Drugs targeting ‘zombie cells’ show promise for treating chronic back pain

Published: 22 April 2025

In a preclinical study led by McGill University researchers, two drugs targeting “zombie cells” have been shown to treat the underlying cause of chronic low back pain. The condition affects...

McGill researchers awarded SSHRC grants to foster collaboration with community partners

Published: 26 June 2024

Two McGill faculty members and their collaborators received Partnership Development Grants from the Social Sciences and Humanities Research Council...

Fighting the flu: The surprising power of a century-old vaccine for tuberculosis

Published: 22 February 2024

As Canada’s flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses. Scholars from the...

Reducing fatigue and errors among nurses working night shifts

Published: 19 April 2023

Nurses exposed to 40 minutes of bright light before their night shifts feel less fatigued and make fewer errors at work, according to a study led by McGill University. The nurses also slept better...

How immune cells generated neonatally protect our lungs throughout our lifetime

Published: 2 February 2023

Every day, humans breathe in 11,000 litres of air. But this essential act also means we inhale microorganisms, particles, and pollutants. A new study from the Research Institute of the McGill...

International consortium investigates overactive immune cells as cause of COVID-19 deaths

Published: 17 April 2020

In the urgent battle to treat COVID-19 patients, a group of eleven international medical research organizations is investigating whether overactive immune cells that produce Neutrophil...

Children in Quebec are not diagnosed early enough with type 1 diabetes

Published: 14 May 2019

Elwyn was a healthy 13 month-old toddler when she started drinking water from the bathtub. Over time, she became increasingly thirsty and demanded more and more breast milk. For her parents, this...

Back to top